Y-Intercept (HK)
ROIV icon

Y-Intercept (HK)’s Roivant Sciences ROIV Stock Holding History

Y-Intercept (HK)’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-110,340
Closed -$3.9M – 2023
2026
Q2 		$3.9M Buy
+110,340
New +$3.26M 0.08% 365
2026
Q1 		– Sell
-67,342
Closed -$1.46M – 1979
2025
Q4 		$1.46M Sell
67,342
-805,739
-92% -$15.9M 0.03% 785
2025
Q3 		$13.2M Buy
873,081
+601,178
+221% +$7.44M 0.32% 45
2025
Q2 		$3.06M Buy
+271,903
New +$2.95M 0.07% 412
2024
Q1 		– Sell
-91,593
Closed -$1.03M – 1700
2023
Q4 		$1.03M Buy
91,593
+52,029
+132% +$507K 0.1% 310
2023
Q3 		$462K Buy
+39,564
New +$447K 0.05% 589

Other funds holding ROIV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Penn Davis McFarland
Penn Davis McFarland Dallas, Texas $1.17B AUM 26.22% 1-Year Est. Return

Y-Intercept (HK)'s ROIV Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Roivant Sciences (ROIV) in Q3 2026, closing a stake of 110,340 shares — an estimated $3.9M sold.

Y-Intercept (HK) first reported a position in ROIV in Q3 2023 and held it in 6 quarters. The position peaked at $13.2M in Q3 2025. 215 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Roivant Sciences position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 110,340 Roivant Sciences shares in Q3 2026, an estimated $3.9M.
  • Y-Intercept (HK) first reported a position in Roivant Sciences in Q3 2023 and held it in 6 quarters.
  • Y-Intercept (HK)'s Roivant Sciences position peaked at $13.2M in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.